THE INVOLVEMENT OF SEROTONIN IN LABOR AND
DELIVERY
Proposal for
Collaborative Research between Bruce E. Morton, Ph.D, Department of
Biochemistry and Biophysics, and X.X. M.D., Department of Obstetrics and
Gynecology, University of Hawaii, 2/22/94
BACKGROUND:
Serotonin (5-hydroxytryptamine, 5-HT) is a neurotransmitter, neuromodulator, and neurohormone both in the central nervous system (CNS) and the periphery. It has been found to modulate many behavioral processes through the at least 14 subclasses of its 5-HT receptors. In the periphery, these processes include regulation of the diameter of the vasculature associated with blood-shunting throughout the brain and body. This is illustrated for example in digestion, headache, or in response to wounding.
Serotonin
also mediates several important CNS behaviors including the stress response,
immune strength, and the predilection for violence toward property, others
(homicide), or oneself (suicide). Thus,
it is central to the production and treatment of several stress disorders
including mania-depression, dysthymia, obsessive compulsive disorder,
pre-menstrual syndrome, anorexia-obesity, and several others, such as autism
and schizophrenia.
Since the
levels of serotonin required to produce its effects are exceedingly small, and
great dilutions are involved in brain dialysis and other experimental
approaches, it is important to have practical, inexpensive assays of adequate
sensitivity. For example, bioassays were
once used for example employing the contracture of the rat uterus (!). In the recent past, the inherent fluorescence
of the serotonin indole ring derivatives at acid pH was utilized in
fluorometric assays of similar sensitivity to the bioassays (>10-8M). These often were not sensitive enough to
detect the small amounts of serotonin required to produce its biological
effects. More recent serotonin assays
have utilized high performance liquid chromatography with electrochemical
detection to reach >2x10-10M sensitivity on protein-free samples.
Dr Morton has
applied the techniques of the radio-receptor assay on unpurified biological
samples to develop an ultrasensitive assay specific for serotonin. It can detect >10-11M serotonin in 100 ul
samples (>10 fmoles). This makes it
the most sensitive serotonin assay known. With this assay, serotonin
concentrations in serum and urine have been measured.
The assay is
sufficiently sensitive to make the measurement of salivary serotonin practical
for the first time. In the process of
learning about human serotonin levels, Dr Morton's group has found that there
is a one hour postprandial elevation of serotonin for one hour, possibly
associated with the shunting of blood away from the peripheral skeletal muscles
to the viscera. Furthermore, they found
that several types of stress produce elevations in salivary serotonin. These include heat stress (such as from
soaking in very hot baths for 30-60 minutes) and exercise stress (such as from
running 30-60 minutes). In experimental
animals, if serum serotonin from heat or exercise stress is elevated beyond a
certain level, the blood brain barrier (BBB) begins to fail. This leads to heat prostration, exhaustion,
altered states of consciousness, and coma by a 5-HT2 receptor mediated process.
In addition,
Dr. Morton's group has found that such serotonin-elevating stress leads to
rapid (within one hour) down-regulation of central 5-HT2a receptors. It is becoming established that in the CNS,
cells bearing 5-HT2a receptors release corticotropin releasing factor
(CRF). CRF, not only activates the HPA
axis in the periphery, but also binds the locus coeruleus (LC) to produce
norepinepherine (NE) release at brain sites causing alarm, temperature elevation,
and other elements of sympathetic nervous system activation.
Thus, it is
appropriate that after more than one hour of stress the 5-HT2 receptors have
been found to be down-regulated, and thus to cease coupling serotonin elevation
to CRF release. For example, by about
one hour, marathon runners experience "the second wind". It is known that 5-HT2a receptors take 3-5
days to return to their usual sensitivity and CRF-releasing response. This is consistent with the several days of
relief from stress (in general) provided by 30-60 minutes of hot tub or
exercise stress. Serotonin reuptake
inhibitor antidepressants, such as fluoxetine (Prozac), reduce stress
ultimately by elevating serotonin to also down-regulate the 5-HT2a receptor
subclass.
It is
noteworthy that brain serotonin levels are very susceptible to amounts of
circulating precursor, tryptophan and also to oxygen availability. Thus, breathing pure oxygen elevates
serotonin levels ten fold in rats, and prolonged hyperventilation has been used
to produce hallucinosis in humans without the use of hallucinogens. Furthermore, all 5-HT2a receptor agonists are
hallucinogens. That is, the hallucinogens act via their ability to mimic the
serotonin normally released by stress-inflammation-mediated interleukin-1 at
the 5-HT2a receptor.
It has
frequently been reported that either low levels of hallucinogens or prolonged
hyperventilation cause the appearance of many labor and delivery associated
symptoms in humans and animals. These
include both rhythmic body thrusting and head pushing, breath-holds,
first-breath associated production of copious chords of mucous, neonate type of
squalling, and suckling (adult rats).
They also produce in adults of either sex a supine posturing with
knee-spreading and pelvic movements which can be so vigorous and prolonged as
to lead to panting from exertion. This
may be followed by a transcendent mental state which may be associated with the
uncommon ecstatic acceptance and bonding of the birth pair at delivery. As an added complication, marked (as great as
ten fold) individual and perhaps racial differences exist in sensitivity to
both antidepressants and hallucinogens.
An earlier
proposal along some of these lines was made to your committee by a colleague,
now retired from UH and living on the mainland.
As you will recall, he proposed to isolate and identify a putative
endogenous hallucinogen, which he erroneously proposed to exist and be produced
during labor and delivery. As predicted,
he failed to find the endogenous hallucinogen.
This is because stress elevated endogenous serotonin release at the
5-HT2a receptor is sufficient to account for all these effects without
requiring an additional endogenous hallucinogen. However, he was correct that a "birth
constellation" of behaviors have been associated with hallucinogen use, if
he mentioned this.
HYPOTHESIS:
Based upon
the above-mentioned multiple layers of evidence, the following model is
proposed: The stress of early labor is
predicted to elevate central and peripheral serotonin levels. As serotonin levels rise toward those
compromising the blood brain barrier, anciently-evolved placental animal
delivery programs are activated in both the mother and the neonate. These lead to the altered mental and physical
behaviors associated with active participation in delivery by both the fetus
and dam. Not to be overlooked is the
known contractile response of the uterus to serotonin itself.
It is further
proposed that in the case of prolonged passive labor, or excessively active
labor, this process can be controlled by the manipulation of 5-HT2 serotonin
tone in the mother. That is, the
appropriate use of oxygen or hyperventilation deliberately to raise serotonin
tone, and use of antagonists, such as ketanserin, to reduce it. Also to be explored at some point is the
possible involvement of serotonin in the respiratory system's transition to air
breathing by the fetus.
In addition
it is proposed that after one hour of high-stress labor, the 5-HT2 receptors
will be down-regulated to produce a "second wind" relief from pain
and anxiety. This will allow a
satisfactory completion of delivery, and will leave the mother and neonate in
positive mental states facilitating bonding.
PROPOSED RESEARCH:
The use of
the salivary serotonin assay would provide a relatively simple way to gather
new fundamental information on the levels of salivary serotonin present during
the various phases of labor.
After first
confirming that salivary serotonin is elevated in stage 2 labor, a more
complete study could be done. In this,
saliva sample collection series on separate patients could be administered as
follows:
1. Before labor begins (to establish serotonin
baseline.)
2. Latent phase: after 60 seconds of hard uterine
contraction.
3. Latent phase: after 5 minutes of relaxation.
4. Early 1st stage: after 60 seconds of hard contraction.
5. Early 1st stage: after 60 seconds of relaxation.
6. Active 1st stage: after 60 seconds of hard contraction.
7. Active 1st stage: after 60 seconds of relaxation.
8. Transition: after 60 seconds of hard contraction.
9. Transition: after 60 seconds of relaxation.
10. 2nd
stage: After 30 seconds of
pushing.
11. 2nd
stage: After 30 seconds of
resting.
12. 3rd
stage: At delivery of placenta.
13. 3rd
stage: 30 minutes after delivery
of placenta
14. 3rd
stage: 2 hours after delivery of
placenta
15. 3rd
stage: 6 hours after delivery of
placenta
Information required on each patient includes race, age,
parity, fetal outcome, and fetal lung maturity.
Based upon
the findings of this fundamental study, it is expected that the subsequent
course of the research will flow as appropriate. For example, if it is confirmed that salivary
serotonin levels are elevated during labor, it would be of interest to compare
the regulatory state of 5-HT2 receptors of placenta coming from mothers
undergoing intense normal vaginal delivery with those whose placenta was
removed after little or no labor by way of cesarian section. It would be important to evaluate the effect
upon salivary serotonin of both hyperventilation and breathing oxygen.
Many other
possibilities suggest themselves, depending upon the findings of the foregoing
proposed research. It may be that this
work would justify the later awarding of substantial extramural funding, both
to the hospital, the medical school, and the present (and perhaps other)
collaborators.